Zusammenfassung
Bei Patienten mit einem VAD/TAH erfolgt eine Gerinnungsaktivierung v.a. an den nicht endothelen Oberflächen der Systeme. Zudem finden sich am Ventrikel akinetische Zonen mit einer Stase des Blutstromes, besonders im Bereich der Inflow-Kanüle, die eine Entstehung von Thromben begünstigen.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Literatur zu 8.1
Boyle AJ, Russel SD, Teuteberg JJ et al (2009) Low thromboembolism and pump thrombosis with the HeratMate II left ventricular assist device: analysis of outpatient anticoagulation. J Heart Lung Transplant 28: 881-887
Casanato A, Sponga S, Pontara E et al (2011). Von Willebrand factor abnormalities in aortic valve stenosis: pathophysiology and impact on bleeding. Thromb and Haemost106: 58-65
Chan YC, Valenti D, Mansfield AO, Stansby G. Warfarin (2000) Induced skin necrosis. Br J Surg 87: 266-272
Demirozu ZT, Radovancevic R, Hochman LF et al (2011) Arteriovenous malformation and gastrointestinal bleeding in patients with the HeartMate II left ventricular assist device. J Heart Lung Transplant 30(8): 849-853
Feher G, Feher A, Pusch G et al (2010) Clinical importance of aspirin and clopidrogel resistance World of Cardiol 26: 171-186
Gaglia MA, Manoukian SV, Waksman R (2010) Novel antiplatelet therapy. Am Heart J 160: 595-604
Geisen U, Heilmann C, Beyersdorf F et al (2008) Non-surgical bleeding in patients with ventricular asist device could be explained by acquired von Willebrand disease. Eur J Cardiothorac Surg 33: 679-684
Houer R, Mazoyer E, Kirsch M et al (2003) J Resistance to aspirin after external ventricular assist device implantation. Thorac Cardiovasc Surg 126: 1636-1637
John R, Kamdar F, Liao K et al (2008) Low thromboembolic risk for patients with the HeartMate II left ventricular assist device. J Thorac Cardiovasc Surg 136: 1318-1323
Kloviate J, Gustafson F, Mortensen SA, Sander K, Nielsen LB (2009) Severely impaired von Willebrand factor dependent platelet aggregation in patients with a continuous flow left ventricular assist device. J Am Coll Cardiol 53: 2162-2167
Koster A, Huebler S, Potapov E et al (2007) Impact of heparin-induced thrombocytopenia on outcome in patients with ventricular assist device support. Single-institution experience in 358 consecutive patients. Ann Thorac Surg 83: 72-76
Krasopoulos G, Brister SJ, Beattle WS, Elliot RF (2008) Aspirin resistance and risk of cardiovascular morbidity: systematic review and meta-analysis. BJM 336: 195-198
Mavrakanas T, Bounameaux H (2011). The potential role of new oral anticoagulants in the prevention and treatment of thromboembolism. Pharmacol Ther 130: 46-58
Meyer AL, Malhesa D, Bara C. et al (2010) Auqired von Willebrand syndrome in patients with an axial flow ventricular assist device. Circ Heart Fail 3: 675-681
Natorska J, Bykoswska K, Hlatwaty M, Marek G, Sadowsky J, Undas A (2011) Increased thrombin generation and platelet activation are associated with deficiency in high molecular weight multimers of von Willebrand factor in patients with moderate to severe aortic stenosis. Heart 97(24):2023-2028, Epub 2011 May 10
O’Brien PJ, Mureebe L (2012) Direct thrombin inhibitors. J Cardiovasc Pharmacol Ther 17(1):5-11, Epub 2011 Feb 18
Otis SA, Zehnder JL (2010) Heparin-induced thrombocytopenia: current status and diagnostic challenges. Am J Hematol 85: 700-706
Panzer S, Eslam RB, Schneller A et al (2010). Loss of high molecular weight von Wilebrand factor multimers mainly affects platelet aggregation in patients with aortic stenosis. Throb Haemost 103: 408-414
Pouplard C, Gueret P, Fouassier M et al (2007) Prospective evaluation of the »4Ts« score and particle gel immunoassay specific to heparin/PF4 for the diagnosis of heparin-induced thrombocytopenia. J Thromb Haemost 5: 1373-1379
Rechner AR (2011) Platelet function testing in clinical diagnostics. Hämostaseologie 31(2): 79-87. Epub 2010 Dec 9
Samuels LE, Kohout J, Casanova-Ghosh E et al (2008) Argatroban as a primary or secondary anticoagulant in patients implanted with a ventricular assist device. Ann Thorac Surg 85: 1651-1655
Savas BS, Asgun F, Oz K, Kuraly E, Tatar H (2007) Warfarin-induced skin necrosis after open heart surgery due to protein S and C deficiency. Heart Vessels 22: 64-66
Saxena R, Sharma P (2009) Gastrointestinal angiodysplasia and acquired von Willebrand Syndrome: a review of an enigmatic association. Journal of Coagulation Dysorders 1(1): 11-16
Schenk S, El-Banayosy A, Prohaska W. et al (2006) Heparin-induced thrombocytopenia in patients receiving mechanical circulatory support. J Thorac Cardiovas Surg 131: 1373-1381
Slaughter MS, Yoshifumi N, John RJ et al (2010) Post-operative heparin may not be required for transitioning patients with a HeartMate II left ventricular assist system to long term warfarin therapy. J Heart Lung Transplant 29: 616-624
Snoep JD, Hovens MMC, Eikenboom JCJ et al (2007) Clopidrogel responsiveness in patients undergoing percutaneous coronary intervention with stenting: a systematic review and meta-analysis. Am Heart J 154: 221-231
Spiess BD (2008) Treating heparin resistance with antithrombin or fresh frozen plasma. Ann Thorac Surg 85: 2153-2160
Steinlechner B, Dworschak M, Birkenburg B et al (2009) Platelet dysfunction in outpatients with left ventricular assist devices. Ann Thorac Surg87: 131-138
Uriel N, Pak SW, Jorde U (2010) Acquired von Willebrand syndrome after continuous flow mechanical support contributes to a high prevalece of bleeding during long-term support and at time of transplantation. J Am Coll Cardiol 56: 1207-1213
Warkentin TE, Greinacher A, Koster A, Lincoff AM (2008) American College of Chest Physicians. Treatment and prevention of heparin-induced thrombocytopenia: American College of Chest Physicians evidence based clinical practice guidelines (8th edition) Chest 133 (6 Suppl.): 340S-380S.
Literatur zu 8.2
Affeld K, Grosshauser J, Reiter K, Grosse-Siestrup C, Kertzscher U (2011) How can we achieve infection-resistant percutaneous energy transfer? Artif Organs 35(8):800-806
Chinn R, Dembitsky W, Eaton L, Chillcott S, Stahovich M et al (2005) Multicenter experience: prevention and management of left ventricular assist device infections. ASAIO J 51(4):461-470
Dembitsky WP, Tector AJ, Park S, Moskowitz AJ, Gelijns AC et al. (2004) Left ventricular assist device performance with long-term circulatory support: lessons from the REMATCH trial. Ann Thorac Surg 78(6):2123-9
von Eiff C, Becker K, Machka K, Stammer H, Peters G (2001) Nasal carriage as a source of Staphylococcus aureus bacteremia. Study Group. N Engl J Med 344(1):11-16
Habib G, Hoen B, Tornos P, Thuny F, Prendergast B et al (2009) ESC Committee for Practice Guidelines. Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and the International Society of Chemotherapy (ISC) for Infection and Cancer. Eur Heart J 30(19):2369-2413
Hannan MM, Husain S, Mattner F, Danziger-Isakov L, Drew RJ et al (2011) International Society for Heart and Lung Transplantation. Working formulation for the standardization of definitions of infections in patients using ventricular assist devices. J Heart Lung Transplant 30(4):375-384
Lador A, Nasir H, Mansur N, Sharoni E, Biderman P et al (2012) Antibiotic prophylaxis in cardiac surgery: systematic review and meta-analysis. J Antimicrob Chemother 2011 Nov 13. [Epub ahead of print], 67(3): 541-550
Literatur zu 8.3
Ambardekar AV, Buttrick PM (2011) Reverse remodeling with left ventricular assist devices:A review of clinical, cellular and molecular effects. Circ Heart Fail4:224-33
Baba HA, Wohlschlaeger J ( 2008) Morphological and molecular changes in the myocardium after left ventricular mechanical support. Curr Cardiol Rev4:157-69
Birks EJ, Tansley PD, Hardy J et al (2006) Left ventricular assist device and drug therapy for the reversal of heart failure. N Engl J Med355:1873-84
Birks E, George RS, Hedger M. et al (2011) Reversal of severe heart failure with a continuous-flow left ventricular assist device and pharmacological therapy. Circulation 118:381-90
Birks EJ, Miller LW (2012) Myocardial recovery with use of ventricular assist devices. In: Kormos RL and Miller LW (eds.) Mechanical Circulatory Support. A Companion to Braunwald’s Heart Disease. Elsevier, Philadelphia , p258-71
Bruggink AH, van Oostehout MF, de Jonge N et al (2006) Reverse remodeling of the myocardial extacellular matrix after prolonged left ventricular device support follows a biphasic pattern. J Heart lung transplant 25:1091-98
Dandel M, Weng Y, Sinawski H, Potapov E, Lehmkuhl HB, Hetzer R (2005) Long-term results in patients with idiopathic dilated cardiomyopathy after weaning from left ventricular assist devices. Circulation 112(suppl.):I-37-45.
Dandel M, Weng Y, Siniawski H, Potapov E, Drews T et al (2008) Prediction of cardiac stability after weaning from ventricular assist devices in patients with idiopathic dilated cardiomyopathy. Circulation 118[suppl 1]:S94-105
Dandel M, Weng Y, Siniawski H. et al (2011) Heart failure reversal by ventricular unloading in patients with chronic cardiomyopathy: criteria for weaning from ventricular assist devices. Eur Heart J;32:1148-60
Dandel M, Potapov E,-Krabatsch T, Weng Y,-Knosalla C,-Hetzer R (2012) Myokarderholung unter mechanischer Ventrikelentlastung und Entwöhnung vom ventrikulären Unterstützungssystem. Z Herz- Thorax- Gefäßchir DOI 10.1007/s00398-012-0939-1
Ferrar DJ, Holmann WR, McBride LR, Kormos RL, Icenogle TB et al (2002) Long-term follow up of Thoratec ventricular assist device bridge-to-recovery patients successfully removed from support after recovery of ventricular function. J Heart Lung Transplant 21(5)516-521
George I, Xydas S, Manicini DM. et al (2006) Effect of clenbuterol on cardiac and skeletal muscle function during ventricular assist device support. J Heart Lung Transplant 25:1084-90.
Hall JL, Fermin DR, Birks EJ et al (2011) Clinical, molecular, and genomic changes in response to left ventricular assist devices. J Am Coll Cardiol 2011 57(6):641-52
Hetzer R, Müller J, Weng Y, et al (1999) Cardiac recovery in dilated cardiomyopathy by unloading with a left ventricular assist device. Ann Thorac Surg 68:742-49
Latif N, Yacoub MH, George R. et al (2007) Changes in sarcomeric and non-sarcomeric cytoskeletal proteins and focal adhesion molecules during clinical myocardial recovery after left ventricular assist device support. J Heart Lung transplant 26:230-235
Müller J, Wallukat G, Weng Y et al (1997) Weaning from mechanical cardiac support in patients with dilated cardiomyopathy. Circulation 96:542-49.
Oriyanhan W, Tsuneyoshi H, Nishina T. et al (2007) Determination of optimal duration of mechanical unloading for failing hearts to achieve bridge to recovery in a rat heterotopic heart transplantation model. J Heart Transplant 26:16-23
Literatur zu 8.4
Allen JG, Weiss ES, Schaffer JM et al (2010) Quality of life and functional status in patients surviving 12 months after left ventricular assist device implantation J Heart Lung Transpl 29:278-285
Andrus S, Dubois J, Jansen C et al (2003) Teaching documentation tool: building a successful discharge. Crit Care Nurse 23:39-48
Bedi M, Kormos R, Winowich S et al (2006) Ventricular arrhythmias during left ventricular assist device support. Am J Cardiol 99:1151-1153
Brewer RJ, Lanfear DE, Sai-Sudhakar CB et al (2012) Extremes of body mass index do not impact mid-term survival after continuous-flow left ventricular assist device implantation. J Heart Lung Transpl 31:167-172
Butler J, Howser R, Portner PM et al (2005) Body mass index and outcomes after left ventricular assist device placement. Ann Thorac Surg 79:66-73
Cavanaugh JL, Miyamoto SD, da Cruz E et al (2010) Predicting recovery: Successful explant of a ventricular assist device in a child with dilated cardiomyopathy. J Heart Lung Transpl 29:105-108
Choong CK, Pasque MK, Shelton K et al (2005) The beneficial role of left ventricular assist device destination therapy in the reversal of contraindications to cardiac transplantation. J Thorac Cardiovasc Surg 130:879-880
Crow S, John R, Boyle A et al (2009) Gastrointestinal bleeding rates in recipients of nonpulsatile and pulsatile left ventricular assist devices J Thorac Cardiovasc Surg 137:208-215
Dandel M, Wenig Y, Siniawski H et al (2008) Prediction of cardiac stability after weaning from left ventricular assist devices in patients with idiopathic dilated cardiomyopathy. Circulation 118 Suppl 14:S94-105
Dang NC, Topkara VK, Kim BT et al (2005) Nutritional status in patients on left ventricular assist device support. J Thor Cardiovasc Surg 130(5):e3-e4
de Jonge N, Kirkels H, Lahpor JR et al (2001) Exercise performance in patients with end-stage heart failure after implantation of a left ventricular assist device and after heart transplantation. JACC 37(7):1794-1799
El-Banayosy A, Fey O, Sarnowski P et al (2001) Midterm follow-up of patients discharged from hospital under left ventricular assistance. J Heart Lung Transpl 20:53-58
Elhenawy AM, Algarni KD, Rodger M et al (2011) Mechanical circulatory support as a bridge to transplant candidacy. J Card Surg 26:542-547
Estep JD, Stainback RF, Little SH et al (2010) The role of echocardiography and other imaging modalities in patients with left ventricular assist devices. JACC: Cardiovasc Imaging 3:1049-1064
Garatti A, Bruschi G, Colombo T et al (2009) Noncardiac surgical procedures in patient supported with long-term implantable left ventricular assist device. Am J Surg 197:710-714
George RS, Yacoub MH, Tasca G et al (2007) Hemodynamic and echocardiographic responses to acute interruption of left ventricular assist device support: relevance to assessment of myocardial recovery. J Heart Lung Transpl 26:967-973
Gordon RJ, Quagliarello B, Lowy FD (2006) Ventricular assist device-related infections. Lancet Infect Dis 6:426-437
Grady KL, Meyer P, Mattea A et al (2001) Improvement in quality of life outcomes 2 weeks after left ventricular assist device implantation. J Heart Lung Transpl 20:657-669
Grady KL, Meyer PM, Dressler D et al (2004) Longitudinal change in quality of life and impact on survival after left ventricular assist device implantation. Ann Thorac Surg 77:1321-1327
Holman WL, Rayburn BK, McGiffin DC et al (2003) Infection in ventricular assist devices: Prevention and treatment. Ann Thorac Surg 75:S48-57
Hozayen SM, Soliman AM, Eckman PM (2012) Comparison of two ventricular assist device dressing change protocols. J Heart Lung Transpl 31:108-109
James KB, Rodkey S, McCarthy PM et al (1998) Exercise performance and chronotropic response in heart failure patients with implantable left ventricular assist devices. Am J Cardiol 81:1230-1232
Jaski BE, Branch KR, Adamson R et al (1993) Exercise hemodynamics during long-term implantation of a left ventricular assist device in patients awaiting heart transplantation. J Am Coll Cardiol 22:1574-1580
John R, Lietz K, Schuster M et al (2003) Immunologic sensitization in recipients of left ventricular assist devices. J Thorac Cardiovasc Surg 125:578-591
Kamiya K, Mezzani A, Masuda T et al (2012) Effects of electrical muscle stimulation in a left ventricular assist device patient. Int J Cardiol Februar 2012 in press, online verfügbar: http://dx.doi. org/10.1016/j.ijcard.2012.01.084
Khan T, Delgado RM, Radovancevic B et al (2003) Dobutamine stress echocardiography predicts myocardial improvement in patients supported by left ventricular assist devices (LVADs): hemodynamic and histologic evidence of improvement before LVAD explantation. J Heart Lung Transpl 22:137-146
Kiernan MS, Pham DT, DeNofrio D et al (2011) Management of HeartWare left ventricular assist device thrombosis using intracavitary thrombolytics. J Thorac Cardiovasc Surg 142:712-714
Kohli HS, Canada J, Arena R et al (2011) Exercise blood pressure response during assisted circulatory support: Comparison of the total artificial heart with a left ventricular assist device during rehabilitation. J Heart Lung Transpl 30:1207-1213
Kushnir VM, Sharma S, Ewald GA et al (2012) Evaluation of GI bleeding after implantation of left ventricular assist device. Gastrointest Endoscop 75:973-979
Lam KM, Ennis S, O’Driscoll G et al (2009) Observations from non-invasive measures of right heart hemodynamics in left ventricular assist device patients. J Am Soc Echocardiogr 22:1055-1062
Maybaum S, Kamalakannan G, Murthy S (2008) Cardiac recovery during mechanical assist device support. Semin Thorac Cardiovasc Surg 20:234-246
Maybaum S, Mancini D, Xydas S et al (2007) Cardiac improvement during mechanical circulatory support: a prospective multicenter study of the LVAD Working Group. Circulation 115:2497-2505
Morales DL, Catanese KA, Helman DN et al (2000) Six-year experience of caring for fourty-four patients with a left ventricular assist device at home: safe, economical, necessary. J Thorac Cardiovasc Surg 119:251-259
Morgan JA, Paone G, Nemeh HW et al (2012) Non-cardiac surgery in patients on long-term left ventricular assist device support. J Heart Lung Transpl 31:757-763
Pamboukian SV, Tallaj JA, Brown RN et al (2011) Improvement in 2-year survival for ventricular assist device patients after implementation of an intensive surveillance protocol. J Heart Lung Transpl 30:879-887
Petrucci RJ, Rogers JG, Blue L et al (2012) Neurocognitoive function in destination therapy patients receiving continuous-flow vs pulsatile-flow left ventricular assist device support. J Heart Lung Transpl 31:27-36
Radovancevic B, Vrtovec B, de Kort E et al (2007) End-organ function in patients on long-term circulatory support with continuous- or pulsatile-flow assist devices. J Heart Lung Transpl 26: 815-818
Richenbacher WE, Seemuth SC (2001) Hospital discharge for the ventricular assist device patient: historical perspective and description of a successful program. ASAIO J 47:590-595
Samuels LE, Holmes Ec, Petrucci R. (2004) Psychosocial and sexual concerns of patients with implantable left ventricular assist devices: a pilot study. J Thorac Cardiovasc Surg 127:1432-1435
Sandner SE, Zimpfer D, Zrunek P et al (2009) Renal function and outcome after continuous flow left ventricular assist device implantation. Ann Thorac Surg 87:1072-1078
Stewart GC, Brooks K, Prathibu PP et al (2009) Thresholds of physical activity and life expectancy for patients considering destination ventricular assist devices. J Heart Lung Transpl 28:863-869
Tjan TDT, Asfour B, Hammel D et al (2000) Wound complications after left ventricular assist device implantation. Ann Thorac Surg 70:538-541
Topilsky Y, Oh JK, Atchison FW et al (2011) Echocardiographic findings in stable outpatients with properly functioning HeartMate II left ventricular assist devices. J Am Soc Echocardiogr 24:157-169
Uchida N, Ishikawa M, Watanabe T et al (1987) Hemodynamic adaptation to exercise after total artificial heart (TAH) implantation. Trans Am Soc Artif Intern Organs 33:240-244
Wadia Y, Etheridge W, Smart F et al (2005) Pathophysiology of hepatic dysfunction and intrahepatic cholestasis in heart failure and after left ventricular assist device support. J Heart Lung Transpl 24: 361-370
Wilson SR, Givertz MM, Stewart GC et al (2009) Ventricular assist devices - The challenges of outpatient management. JACC 54:1647-1659
Zimpfer D, Zrunek P, Roethy W et al (2007) Left ventricular assist devices decrease fixed pulmonary hypertension in cardiac transplant candidates. J Thorac Cardiovasc Surg 133:689-695
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Boeken, U., Assmann, A., Born, F., Schmid, C. (2013). VAD-Nachsorge. In: Boeken, U., Assmann, A., Born, F., Schmid, C. (eds) Mechanische Herz-Kreislauf-Unterstützung. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-29408-2_8
Download citation
DOI: https://doi.org/10.1007/978-3-642-29408-2_8
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-29407-5
Online ISBN: 978-3-642-29408-2
eBook Packages: Medicine (German Language)